CAVA heads into its May 19 earnings report in an awkward spot: shorts have covered aggressively, yet the stock is still down 15% on the week, sitting at $77.18.
Short sellers have been steady sellers of their positions throughout May. SI % of FF has dropped from a peak of over 15.6% in early April to 12% now — a meaningful cover of roughly a quarter of the short book in six weeks. That unwind has done nothing to arrest the price decline, which is the telling part. When covering doesn't produce a rally, it usually means there's fresh selling pressure elsewhere. Availability in the lending pool remains loose relative to recent highs — the 52-week peak in availability tightness was hit in early April — so there is no mechanical squeeze forcing the cover; this looks like a deliberate repositioning. Cost to borrow is a negligible 0.43%, down from 0.80% in early April, confirming there is no scarcity in the borrow market. Options positioning adds little urgency either way: the put/call ratio is 0.61, essentially in line with its 20-day average of 0.60, and well below the 52-week defensive peak of 0.91.
The Street, by contrast, has been busy upgrading its view of the fundamentals. Nearly every major firm raised its price target since late April — JP Morgan to $90, RBC Capital to $100, KeyBanc to $105, and Benchmark to $110. Most recently, UBS lifted to $85 on Tuesday even while holding a Neutral rating, and Goldman Sachs moved to $86 in mid-April from $75. The consensus target is now around $89.65 — about 16% above the current price — but the clustering of Neutral ratings from UBS, Goldman, and Citi tells the real story. Bulls can point to CAVA's position as the dominant Mediterranean fast-casual brand, durable same-store sales growth, and a long store-expansion runway across 26 states. Bears point to the obvious: a P/E north of 128x and an EV/EBITDA of 44x leave zero room for macro softness or any stumble in consumer spending. The EV/EBITDA multiple has already compressed by about 3 points over the past month as the price has come in. The EPS momentum score ranks in the 84th percentile on a 30-day basis, suggesting the revision trend has been positive — but that has not been enough to defend the share price this week.
Peer context sharpens the picture. SHAK collapsed 32% on the week, dragging the fast-casual cohort with it. BROS dropped 11%. SG fell 4.5%. CAVA's 15% decline is severe, but it is not isolated — the entire segment has been repriced. CAKE and DIN were relative outperformers, down less than 1% and up 5% respectively, reflecting the market's preference for value-priced dining concepts over premium growth names when consumer confidence wavers.
Insider activity tilts one way: all recent trades have been sales. The most recent was a $721k disposal by founder Ted Xenohristos on May 11, the day before Tuesday's close. Earlier in the quarter the CLO sold $1.2m worth at $80.33. Net insider selling over 90 days totals roughly $4.8m. None of these look like panic — the trade sizes are small relative to holdings and significance scores are low — but there is no insider buying to counterbalance the trend.
The earnings print on May 19 is the next hard catalyst. The last report in February produced a 25% single-day move higher, and the five-day follow-through added another 13%. With the stock now more than 20% below that post-earnings peak and valuation still elevated, the question heading into the release is whether the growth narrative — same-store sales, new unit economics, guidance cadence — can hold up under a consumer backdrop that has clearly rattled the rest of the sector.
See the live data behind this article on ORTEX.
Open CAVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
